Biogen's Alzheimer's drug isn't FDA-approved yet, but it may already have a name
Biogen recently filed a trademark application for an Alzheimer's disease drug brand name and logo.
More from North Carolina Business
Business North Carolina Magazine
Systel founder Keith Allison steps into chairman role as daughters lead company
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Krispy Kreme posts $19M loss as restructuring follows McDonald's breakup
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Gov. Stein touts N.C.'s biotech, EV strength after Asia trade trip
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
FEMA sends $155M for Helene recovery, projects in western N.C.
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
New N.C. program helps small businesses offer health insurance
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Trump-backed $80B Westinghouse plan could lead to U.S. stake, IPO
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Nvidia CEO predicts China will surpass U.S. in AI race
North Carolina Business
•
Nov 6, 2025
Business North Carolina Magazine
N.C. insurers propose 68% hike in dwelling policy rates
North Carolina Business
•
Nov 6, 2025